Biogen | BIIB - Mitarbeiter Gesamtzahl





Mitarbeiter Veränderung Datum
AbbVie 55K 5K 2024-12
Acadia Pharmaceuticals 653 56 2024-12
ALKERMES 1.8K 300 2024-12
Amgen 28K 1.3K 2024-12
Bayer 99.72K 1.65K 2023-12
Biogen 7.6K 35 2024-12
BioMarin Pharmaceutical 3.04K 361 2024-12
Bristol-Myers Squibb 34.1K 0 2024-12
Eli Lilly 47K 4K 2024-12
Esperion Therapeutics 240 41 2023-12
Gilead Sciences 17.6K 400 2024-12
Incyte 2.62K 93 2024-12
Merck 75K 3K 2024-12
Moderna 5.8K 200 2024-12
Neurocrine Biosciences 1.8K 400 2024-12
Novartis USD 101.7K 2.62K 2022-12
Pfizer 81K 7K 2024-12
PTC Therapeutics 939 49 2024-12
Puma Biotechnology 185 7 2023-12
Regeneron Pharmaceuticals 13.45K 1.6K 2023-12
Sangamo BioSciences 405 73 2023-12
Sanofi 84.59K 3.41K 2024-12
Sanofi EUR 91.57K 3.87K 2022-12
Sarepta Therapeutics 1.37K 58 2024-12
Ultragenyx Pharmaceutical 1.29K 18 2024-12
United Therapeutics 1.3K 137 2024-12
Vertex Pharmaceuticals 6.1K 700 2024-12